This is especially true for people with exercise-induced asthma or EIB. For these people, their asthma symptoms are triggered ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.